acetylphenylalanyl-prolyl-boroarginine has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gustafsson, D; Lenfors, S | 1 |
Kettner, CA; Knabb, RM; Reilly, TM; Timmermans, PB | 1 |
2 other study(ies) available for acetylphenylalanyl-prolyl-boroarginine and Disease Models, Animal
Article | Year |
---|---|
New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
Topics: Animals; Antithrombins; Arginine; Batroxobin; Boron Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolysis; Injections, Intravenous; Male; Oligopeptides; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombin | 1996 |
In vivo characterization of a new synthetic thrombin inhibitor.
Topics: Animals; Boron Compounds; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Male; Oligopeptides; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Rats; Rats, Inbred Strains; Thrombin; Thrombin Time; Thrombophlebitis; Thrombosis | 1992 |